Venable, Winston Lose CAFA Removal Bid in Illinois Depakote Litigation

, The Litigation Daily


The Class Action Fairness Act is a formidable obstacle for plaintiffs lawyers hoping to litigate big multi-plaintiff cases in state court. But it wasn't enough for Abbott's lawyers in a series of cases alleging that the company's anti-seizure drug Depakote causes birth defects.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisAdvance® Here

Not a LexisAdvance® Subscriber?

Subscribe Now

Why am I seeing this?

LexisAdvance® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisAdvance® customers will be able to access and use ALM's content by subscribing to the LexisAdvance® services via® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Legaltech News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisAdvance® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202549450898

Thank you!

This article's comments will be reviewed.